Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00046332 | A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients | PHASE2 | COMPLETED | 100 | — | — | Jun 1, 2002 | Jan 1, 2003 | Feb 21, 2013 | 23 | United States |
| Name | Type | Description |
|---|---|---|
| GW810781 | DRUG | - |
Inclusion Criteria: * No prior HIV medications. * HIV infection with viral load \>400-50,000 copies/mL. * CD4 cell count \>50 cells/mm. Exclusion Criteria: * Patients requiring medications that cannot be interrupted for the duration of the study. * Abnormal ECG or other chronic health conditions ...